Adverum Biotechnologies reports positive financial results, progress with Ixo-vec gene therapy for wet AMD.
From GlobeNewswire: 2025-04-15 07:40:00 Adverum Biotechnologies, Inc. reported financial results for Q4 and full year 2024, highlighting the potential of